Article
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.
Nature genetics - 1 Jul 2013
Carvill Gemma L, Heavin Sinéad B, Yendle Simone C, McMahon Jacinta M, O'Roak Brian J, Cook Joseph, Khan Adiba, Dorschner Michael O, Weaver Molly, Calvert Sophie, Malone Stephen, Wallace Geoffrey, Stanley Thorsten, Bye Ann M E, Bleasel Andrew, Howell Katherine B, Kivity Sara, Mackay Mark T, Rodriguez-Casero Victoria, Webster Richard, Korczyn Amos, Afawi Zaid, Zelnick Nathanel, Lerman-Sagie Tally, Lev Dorit, Møller Rikke S, Gill Deepak, Andrade Danielle M, Freeman Jeremy L, Sadleir Lynette G, Shendure Jay, Berkovic Samuel F, Scheffer Ingrid E, Mefford Heather C
Abstract excerpt
Epileptic encephalopathies are a devastating group of epilepsies with poor prognosis, of which the majority are of unknown etiology. We perform targeted massively parallel resequencing of 19 known and 46 candidate genes for epileptic encephalopathy in 500 affected individuals (cases) to identify new genes involved and to investigate the phenotypic spectrum associated with mutations in known genes. Overall, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.